Directors' Dealing

RNS Number : 0779L

Ergomed plc

16 April 2018

 

Ergomed Plc

("Ergomed" or the "Company")

Directors' Dealing

Ergomed, a profitable UK-based group dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, announces that on 16 April 2018, Dr Miroslav Reljanovic, founder and Executive Vice-Chairman of the Company, sold 4,000,000 ordinary shares of 1p each in the Company ("Share(s)") at a price of 190p per Share to meet institutional demand. 

Following this transaction, Dr Miroslav Reljanovic's holding has reduced to 11,132,237 shares (representing 24.9 per cent. of the Company's issued share capital).

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Dr Miroslav Reljanovic
2	Reason for the notification
a)	Position/status	Founder and Executive Vice-Chairman
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Ergomed Plc
b)	Legal Entity Identifier	213800BVS8I9VMC1AP84
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 1 pence each  GB00BN7ZCY67
b)	Nature of the transaction	Sale of shares
c)	Currency	GBP
d)	Price(s) and volume(s)	Price(s)	Volume(s)
		190p	4,000,000
e)	Aggregated information - Aggregated volume - Price - Aggregated total	Volume: 4,000,000 Price: 190p Aggregated volume: £7,600,000
f)	Date of the transaction	16 April 2018
g)	Place of the transaction	London Stock Exchange, AIM

Enquiries:

Ergomed plc	Tel: [phone]
Stephen Stamp (Chief Executive Officer)
Numis Securities Limited	Tel: [phone]
Michael Meade / Freddie Barnfield (Nominated Adviser)
James Black (Joint Broker)

 

END

 

 

DSHIFMITMBABBJP